Thiogenesis Therapeutics, Inc.
TTIPF · Toronto, Ontario, Canada
Works in Cardiovascular · Genetic & rare · Infectious disease · Metabolic & endocrine · Musculoskeletal · Neurology · Respiratory
Thiogenesis Therapeutics, Inc. is a clinical trial sponsor based in Toronto, Ontario, Canada, listed as TTIPF. It has 2 active clinical trials with 24 planned participants, across 7 therapeutic areas. Since 2021 it has completed 1 trial and stopped 1 early.
Trial track record · since 2021
Financials · TTIPF
Fundraising
Pipeline · 2 active trials
| Stage | Trial | Status |
|---|---|---|
Questions about Thiogenesis Therapeutics, Inc
Thiogenesis Therapeutics, Inc is lead sponsor of 2 active clinical trials on ClinicalTrials.gov, with 24 planned participants, in Cardiovascular, Genetic & rare, Infectious disease, Metabolic & endocrine and other areas. Since 2021 it has completed 1 trial and stopped 1 early.
Thiogenesis Therapeutics, Inc is based in Toronto, Ontario, Canada and is listed as TTIPF. The address is the one on its SEC filings, which name the establishment or the registrant, not always the group's head office.
From public sources only: ClinicalTrials.gov for trials, FDA's Data Dashboard, warning-letter listing and enforcement reports for the FDA record, and SEC filings for financials. Approve Suite is not affiliated with Thiogenesis Therapeutics, Inc; every record links to the source, and nothing here is advice.
See the rest of this profile
A free account shows the trial list, the financials and the fundraising filings. Pro adds a watchlist: one email when FDA acts on a company you name.
Trial counts are as the sponsor reported them to ClinicalTrials.gov, for trials changed since 2021; latest update 2026-09-23.
Approve Suite is not affiliated with Thiogenesis Therapeutics, Inc..
See something wrong on this page? Write to info@approvesuite.com and we will check it against the source. How corrections work.